Current insight in the localized insulin-derived amyloidosis (LIDA): clinico-pathological characteristics and differential diagnosis
Conclusion The identification of amyloid material and immunoreactivity with anti-insulin antibodies are key diagnostic features of LIDA. Although several clinical and animal studies were made in recent years, the lesion is still under-diagnosed and underreported. The clinical suspicion and knowledge of the lesion play a crucial role for the accurate diagnosis of LIDA. Surgical excision of the lesion can dramatically decrease insulin requirement and improve glycemic control.
Source: Pathology Research and Practice - Category: Pathology Source Type: research
More News: Allergy & Immunology | Amyloidosis | Brain | Cardiology | Cardiomyopathy | Diabetes | Endocrinology | Heart | Hypertrophic Cardiomyopathy | Insulin | Neurology | Pathology | Proteinuria | Study